The Food and Drug Administration announced in February that it was exercising its enforcement discretion for the temporary importation of Lipodox®, in order to help alleviate the Doxil® shortage. Additional information regarding Lipodox and its importation is available from the following sources:
- A bulletin from the American Society of Health-System Pharmacists (ASHP)
- A table from ASHP showing a comparison of Doxil and Lipodox
- A “Dear Healthcare Professional” letter from Sun Pharma, manufacturer of Lipodox
- The most recent update on the Doxil supply shortage from the manufacturer of Doxil